NHS英格兰东南区上线皮肤癌AI DERM,可自主让患者出院
伦敦公司 Skin Analytics 的 DERM 将从今年秋季起在英格兰东南部全部 18 家 NHS 信托上线,覆盖另外约 900 万人,为期三年;公司称这是 NHS 历史上规模最大的自主医疗 AI 部署。DERM 会分析疑似皮肤癌转诊时拍摄的病灶图像,若判定为良性,NHS 可在分诊阶段直接让患者出院,被标记为高风险的则更快转诊给专科医生。该公司称 DERM 是首个也是唯一获得 III 类 CE 认证、可用于自主判断的 AI,并称已评估逾 25 万名患者、发现逾 2.5 万例癌症;其自报监测数据显示 DERM 排除皮肤癌的准确率为 99.5%,检出约 98% 的皮肤癌。
若这套自动化分诊在三年推广中经受住验证,它将成为监管机构如何看待“无需医生复核即可放行患者”的医疗 AI 的重要参照案例。

NHS England’s South East region is rolling out an AI that can discharge patients with harmless skin lesions without a dermatologist seeing them. DERM, made by London-based Skin Analytics, goes live in all 18 NHS trusts there from this autumn. It will cover another 9 million people.
Skin Analytics announced the rollout on Wednesday and called it the largest deployment of autonomous medical AI in NHS history. The rollout runs for three years.